FILTER

Refine your search with the following facets to narrow down your results.

18 Current news of Lab21

Lab21 announces sale of South Carolina Operations

14-Jan-2013 - Lab21 Limited announced the sale of its laboratory operations based in South Carolina to Reedy Acquisitions Corp, an entity formed by the existing local management and South Carolina based investors. In addition to an immediate cash benefit for Lab21 Ltd, the sale will remove a loss-making ...

Lab21 secures European and USA patents for HCV drug resistance genotyping

18-May-2012 - Lab21 Limited has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious disease testing. The patents cover technology allowing the genotypic identification of drug resistant mutations ...

drug resistance genotyping hepatitis C +1

Lab21 launches new lung cancer companion diagnostic service

20-Feb-2012 - Lab21 Limited has launched a new Companion Diagnostic testing service for non-small cell lung cancer patients.The EML4-ALK companion diagnostic test for translocations in the ALK gene will allow physicians to select lung cancer patients likely to respond to ALK inhibitor therapy. The test uses ...

companion diagnostics diagnostics non-small cell lung cancer

Lab21 Wins Biomedical Project of the Year Award

01-Dec-2011 - Lab21 Limited has won the BioNow Biomedical Project of the Year Award for its MycAssay product line. The BioNow Biomedical Project of the Year Award recognises individuals or organisations who have demonstrated an innovative solution to a specific industry problem. Lab21’s MycAssay Aspergillus ...

Aspergillus BioNow Biomedical Project of the Year Award PCR assays

Lab21 Announces Positive Results for Aspergillus Detection in Critical Care and Haematology Patients

14-Nov-2011 - Lab21 Limited has announced the completion of an evaluation of a commercial PCR test, its MycAssayTM Aspergillus assay, to detect invasive Aspergillosis (IA) in a mixed population of 158 patients with underlying haematological or critical illness. The prospective evaluation was performed by ...

Aspergillus diagnostics PCR

Lab21 Extends CPA Accreditation

02-Nov-2011 - Lab21 Limited has announced that its Clinical Laboratory Division has extended its Clinical Pathology Accreditation (CPA) scope to include Molecular Biology and Virology in addition to Biochemistry. The accreditation was awarded by Clinical Pathology Accreditation (UK), the quality assurance ...

accreditation Good Clinical Laboratory Practice in-vitro diagnostics +2

Lab21 acquires molecular diagnostics company Myconostica Ltd

25-May-2011 - Lab21 Limited has announced that it has acquired Myconostica Ltd. The financial terms of the deal were not disclosed. The acquisition of Myconostica expands Lab21’s growing proprietary diagnostic portfolio and will provide the Company’s first set of nucleic acid-based assays. Furthermore it will ...

acquisitions diagnostics

Lab21 acquires Microgen Bioproducts

10-Jan-2011 - Lab21 Limited announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests to identify diseases and organisms which pose a threat to health. Microgen Bioproducts’ expertise in microbiological assay development and ...

Lab21 appoints Susan Lowther as Chief Financial Officer

29-Oct-2010 - Lab21 Limited announced the appointment of Susan Lowther as Chief Financial Officer. Susan brings a wealth of experience, gained over 20 years in the pharmaceutical, biotech and healthcare industries. She has extensive financial management expertise, gained from working with start up companies ...

Lonza Monsanto

Lab21 expands its range of cardiovascular genetic tests with Clinical Data, Inc.

29-Sep-2008 - Lab21 announced the expansion of its portfolio of genetic tests for inherited cardiac syndromes. Through its existing UK licence with PGxHealth™, a division of Clinical Data, Inc., Lab21 offers exclusive U.K. and Ireland access to the Familion® portfolio of tests for Long QT and Brugada ...

Ireland